Stock Updates

How has Gilead Sciences Inc.:(NASDAQ:GILD) performed recently?

Gilead Sciences Inc. (NASDAQ: GILD) is a large market cap stock with a market cap of 116019.87. It is in the Biotechnology industry and sector Healthcare, with a current P/E of 7.18, a forward P/E of 6.8 and EPS of 11.69. At a stock price of 83.89 (-1.14%) it has a dividend yield of 2.24%.

EPS growth for the last five years have been 48.30%, more recently this last year it has grown by 62.00%. The next year growth is going to be about 2.24% and more long-term 0.65% after five years. EPS growth quarter over quarter is -8.60%. Sales growth for the past five years have been 32.60% and sales growth quarter over quarter is 2.60%.

For performance, Gilead Sciences Inc. the past week has seen a gain of 7.21%. For the last month performance for Gilead Sciences Inc. is -2.08%. While the last quarter is -11.73% and half year, -13.51%. Finally for the year, performance is -26.10%.

The 52-week high for Gilead Sciences Inc., is at -28.99%, and for the 52-week low it comes to a value of 7.66%. The 20-day simple moving average is -2.15% and -10.62% for the 200-day simple moving average.

Volatility for the week is at 2.64%, and for the month it is 2.09%. Gilead Sciences Inc., has a target price of 110.89.

In terms of debt, long term debt/equity is 1.57, and for total debt/equity Gilead Sciences Inc. has 1.7. The gross margin is 86.90%, while operating margin is 65.40%, the profit margin is 52.80%. The current ratio is 1.8 and the quick ratio is 1.6.

Insider ownership is at 0.50%, with instituitional ownership at 81.90%. Gilead Sciences Inc. has a payout ratio of 14.30%. With the total shares outstanding coming to 1383. The shares float is 1322.84, with the float short at 1.87%, with short ratio coming to 2.55.

In terms of returns, the return on assets see Gilead Sciences Inc., get 36.60%, with its returns on investment at 45.90%. Return on equity is 105.70%. So will the investors see the target price of 110.89, reached soon?

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.


About the author

Mark Hines

Leave a Comment